• home
• About Silence Therapeutics
• Therapeutic Platform
• Pipeline
• Intellectual Property
• Collaborations
• Science of RNAi
• Investor Relations
• News and Events

collaborations

Licensing

Silence is seeking partners that will be instrumental in accelerating the company’s pipeline of RNAi therapeutic candidates.